Laserfiche WebLink
*For Information Onlv: <br />Funding is not tied to the revised Standards/lr4easures listed here._ This information may be helpful in discussions ofhow program aclivities might contribute to meeting aStandard/Measure More detail on these and./or other Public Health Accreditation Board (PHAb) Standards,Measures thai miy apply can be foind at: <br />htto://www.phaboard.ordwp-contenvuploads/pHAB-standards-and-Measures-Version- l.0.pdf <br />AMENDMENT#I8 <br />Contract Number CLHI 8249-l 8 <br />Exhibit A, Statements of Work <br />Revised as ofNovember 16,2020 <br />Page 14 of 34 <br />Task <br />Number Task/Activity/Description *May Support PHAB <br />Standards/Measures Deliverables/Outcomes Due Date/Time Frame <br />Payment <br />Information and/or <br />Amount <br />COVID-|9 Vaccine Services - Tnsk 3 <br />3.4 oclivily. crclivities to support OOVID vtrccine <br />response in your communily, using lhe examples below tts ct <br />guideline. <br />Etample 1: l)evelop and implement cornmunicotion <br />slralegies wilh health coe provider.s, community, on.l/or <br />olllar paflners to help build vaccine confidence broadly and <br />among groups qnticipoted to receive eil'ly vaccinstion, us <br />well as dispel vaccine misinfonnation. Documanl ond <br />provide a pkm that show,s lhe commtuicdion strolegies <br />used with health ctrre prcviders und other partners and the <br />Iocally identilied population onticipoted to reach. <br />Etantple 2: lingugc in other vaccination plonning activities <br />sttch us partnership development, ptovider educrtion, <br />voccinolion point ol dispensing (POD) planning, tabletop <br />exercises, engogement wilh communilies, leaders, non- <br />truditionul provider, or yulnercthle populetions to detelop <br />slr'olegies lo ensurc equiloble access to ruccinalion seruices <br />Summcuy ofthe <br />engctgemenl slrulegies to <br />be used with henhh care <br />providets and other <br />pafiners, and the locally <br />identifted population to be <br />ruched. <br />Januuy 3), 2021 I 11,582 FFy2t <br />COVIDl9 <br />VACCIN]] <br />SE]]VICDS.CAIIIiS <br />[,unding <br />(Mr 713 10209) <br />3.R communiul i on sl rul egies or 0ctivilies, <br />working with heafth care provitlen ond other pailners to <br />rcach the locally identilied population, suppott providers in <br />vaccinotion plans, ond support equitable access to <br />vqccination seruices. <br />Mid-term u,ritten repofl <br />describing <br />0cl il,ily/aclivi lies and <br />progress modc to-date <br />qnd slrategies used <br />(temolate lo be orovided) <br />March 31,2021 <br />3.C (inolog uctivities and conduct un evoluotion ofthe <br />slralegie,\ used <br />Fin1l written rcport, <br />showing the strategies <br />used and thc.finol <br />progress ofthe reach <br />(temnlate to be w'ot,ided) <br />June 30,2021